×
Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population. PDF
$ 40.00
Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population. PDF quantity
$ 40.00
×
Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression PDF
$ 40.00
Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression PDF quantity
$ 40.00
×
Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder PDF
$ 40.00
Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder PDF quantity
$ 40.00
×
Co-Occurrence of Binge Eating Disorder With Psychiatric and Medical Disorders PDF
$ 40.00
Co-Occurrence of Binge Eating Disorder With Psychiatric and Medical Disorders PDF quantity
$ 40.00
×
Trauma at the Hands of Another: Distinguishing PTSD Patterns Following Intimate and Nonintimate Interpersonal and Noninterpersonal Trauma in a Nationally Representative Sample PDF
$ 40.00
Trauma at the Hands of Another: Distinguishing PTSD Patterns Following Intimate and Nonintimate Interpersonal and Noninterpersonal Trauma in a Nationally Representative Sample PDF quantity
$ 40.00
×
A Randomized Trial of Concurrent Smoking-Cessation and Substance Use Disorder Treatment in Stimulant-Dependent Smokers PDF
$ 40.00
A Randomized Trial of Concurrent Smoking-Cessation and Substance Use Disorder Treatment in Stimulant-Dependent Smokers PDF quantity
$ 40.00
×
Symptoms of Depression in a Hispanic Primary Care Population With and Without Chronic Medical Illnesses PDF
$ 40.00
Symptoms of Depression in a Hispanic Primary Care Population With and Without Chronic Medical Illnesses PDF quantity
$ 40.00
×
Pisa Syndrome (Pleurothotonus): Report of a Multicenter Drug Safety Surveillance Project PDF
$ 40.00
Pisa Syndrome (Pleurothotonus): Report of a Multicenter Drug Safety Surveillance Project PDF quantity
$ 40.00
×
Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression PDF
$ 40.00
Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression PDF quantity
$ 40.00
×
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia PDF
$ 40.00
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia PDF quantity
$ 40.00
×
Effectiveness of Aripiprazole, Olanzapine, Quetiapine, and Risperidone Augmentation Treatment for Major Depressive Disorder: A Nationwide Population-Based Study PDF
$ 40.00
Effectiveness of Aripiprazole, Olanzapine, Quetiapine, and Risperidone Augmentation Treatment for Major Depressive Disorder: A Nationwide Population-Based Study PDF quantity
$ 40.00
×
Optimizing the Detection of Bipolar II Disorder in Outpatient Private Practice: Toward a Systematization of Clinical Diagnostic Wisdom PDF
$ 40.00
Optimizing the Detection of Bipolar II Disorder in Outpatient Private Practice: Toward a Systematization of Clinical Diagnostic Wisdom PDF quantity
$ 40.00
×
Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study PDF
$ 40.00
Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study PDF quantity
$ 40.00
×
A Model of the Economic Impact of a Bipolar Disorder Screening Program in Primary Care PDF
$ 40.00
A Model of the Economic Impact of a Bipolar Disorder Screening Program in Primary Care PDF quantity
$ 40.00
×
A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction PDF
$ 40.00
A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
